Fri, June 7, 2024
Thu, June 6, 2024
Wed, June 5, 2024
Tue, June 4, 2024
Mon, June 3, 2024
Fri, May 31, 2024

Keay Nakae Maintained (ABUS) at Strong Buy and Held Target at $4 on, Jun 5th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ng-buy-and-held-target-at-4-on-jun-5th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Keay Nakae of Chardan Capital, Maintained "Arbutus Biopharma Corporation" (ABUS) at Strong Buy and Held Target at $4 on, Jun 5th, 2024.

Keay has made no other calls on ABUS in the last 4 months.



There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Keay's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Keay


  • Roy Buchanan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Thursday, April 4th, 2024
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $5 on, Friday, March 1st, 2024

Publication Contributing Sources